Showing results (11-20 of 148) with videos related to
Sort By:
Pageof 15
Current Treatment Options in Oncology|May 5, 2005
Treatment of metastatic malignant melanomaEhab Atallah, Lawrence FlahertyClinical Advances in Hematology & Oncology : H&O|August 8, 2007
Use of hypomethylating agents in myelodysplastic syndromesEhab Atallah, Guillermo Garcia-ManeroCurrent Opinion in Hematology|December 2, 2005
Granulocyte transfusionEhab Atallah, Charles A SchifferCancer Investigation|February 9, 2008
Treatment strategies in myelodysplastic syndromesEhab Atallah, Guillermo Garcia-ManeroHaematologica|October 15, 2020
Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: when and for whom?Ehab Atallah, Charles A SchifferCurrent Hematologic Malignancy Reports|February 17, 2016
Quality of Life and Long-Term Therapy in Patients with Chronic Myeloid LeukemiaKathryn E Flynn, Ehab AtallahHaematologica|December 11, 2025
Improving quality of life for patients with chronic myeloid leukemia through supportive care, low-dose therapy, switching, and treatment-free remissionKathryn E Flynn, Ehab AtallahHematology/Oncology and Stem Cell Therapy|June 26, 2023
Venetoclax-based Treatment as Frontline Therapy for Chronic Lymphocytic LeukemiaGuru Subramanian Guru Murthy, Ehab AtallahCurrent Hematologic Malignancy Reports|January 16, 2019
Treatment-Free Remission in CML: the US PerspectiveGuru Subramanian Guru Murthy, Ehab AtallahClinical Lymphoma & Myeloma|March 27, 2007
Emerging safety issues with imatinib and other Abl tyrosine kinase inhibitorsEhab Atallah, Hagop Kantarjian, Jorge CortesPageof 15